Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Pain, Postoperative 3Pain 2Neoplasm Metastasis 2Hematologic Neoplasms 2Vesico-Ureteral Reflux 1Ureteral Neoplasms 1Supratentorial Neoplasms 1Pain, Intractable 1Nephrolithiasis 1Neoplasms 1Multiple Myeloma 1Mucositis 1Lymphoma 1Liver Neoplasms 1Leukemia 1Leiomyoma 1Kidney Neoplasms 1Ileus 1Chronic Pain 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Agnosia 1Advanced Malignant Neoplasm 1

Interventions

Xylitol 1Pentoxifylline 1Passive Cutaneous Anaphylaxis 1Morphine 1Methadone 1Low-Level Light Therapy 1Hydromorphone 1Folic Acid 1Drug Therapy 1Betaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mucositis × Morphine × 1 year × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡